REATA PHARMACEUTICALS INC Deferred Revenue
REATA PHARMACEUTICALS INC had Deferred Revenue of $28.84 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-05-08
- 2018-03-31: Deferred Revenue, Current $28.84M.
- 2017-12-31: Deferred Revenue, Current $28.18M.
- 2017-09-30: Deferred Revenue, Current $30.59M.
- 2017-06-30: Deferred Revenue, Current $35.98M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-03-31 | $28.84M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $28.18M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $30.59M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $35.98M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $41.32M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $46.60M 10-K · filed 2018-03-02 |
| 2016-09-30 | $49.59M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $49.59M 10-Q · filed 2016-08-11 |
| 2015-12-31 | $49.73M 10-K · filed 2017-03-03 |